Novartis Transplant Drug Certican Delayed by FDA (Update1) Novartis AG, Switzerland #39;s largest drugmaker, said the US Food and Drug Administration has delayed approval of its Certican transplant treatment and is seeking more information on safe and effective dosing. 
What label best describes this news article? 